LHC Group (NASDAQ:LHCG) Now Covered by Deutsche Bank

Share on StockTwits

Deutsche Bank assumed coverage on shares of LHC Group (NASDAQ:LHCG) in a report published on Monday, BenzingaRatingsTable reports. The brokerage issued a buy rating and a $145.00 price objective on the health services provider’s stock.

Several other research firms have also issued reports on LHCG. Barclays boosted their price target on LHC Group from $113.00 to $120.00 and gave the company an equal weight rating in a report on Friday, August 9th. Oppenheimer boosted their price target on LHC Group from $125.00 to $146.00 and gave the company an outperform rating in a report on Friday, August 9th. Zacks Investment Research upgraded LHC Group from a hold rating to a buy rating and set a $130.00 price objective on the stock in a research report on Thursday, June 27th. Royal Bank of Canada set a $135.00 price objective on LHC Group and gave the company a buy rating in a research report on Friday, August 9th. Finally, BidaskClub upgraded LHC Group from a buy rating to a strong-buy rating in a research report on Friday, August 2nd. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. LHC Group has a consensus rating of Buy and a consensus target price of $129.70.

NASDAQ:LHCG opened at $118.06 on Monday. The stock has a 50-day simple moving average of $120.41 and a two-hundred day simple moving average of $115.78. LHC Group has a 52-week low of $80.84 and a 52-week high of $129.37. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.59 and a current ratio of 1.59. The firm has a market capitalization of $3.72 billion, a PE ratio of 33.26, a P/E/G ratio of 1.96 and a beta of 0.85.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.07 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.06. LHC Group had a return on equity of 8.83% and a net margin of 4.20%. The business had revenue of $517.84 million during the quarter, compared to analyst estimates of $524.24 million. During the same quarter in the previous year, the company posted $0.84 earnings per share. LHC Group’s revenue for the quarter was up 3.2% on a year-over-year basis. Equities analysts forecast that LHC Group will post 4.34 earnings per share for the current fiscal year.

Several institutional investors have recently made changes to their positions in LHCG. Geode Capital Management LLC lifted its position in shares of LHC Group by 6.7% in the fourth quarter. Geode Capital Management LLC now owns 325,548 shares of the health services provider’s stock valued at $30,562,000 after acquiring an additional 20,482 shares in the last quarter. Janus Henderson Group PLC lifted its position in shares of LHC Group by 21.9% in the first quarter. Janus Henderson Group PLC now owns 5,308 shares of the health services provider’s stock valued at $588,000 after acquiring an additional 955 shares in the last quarter. Rhumbline Advisers lifted its position in shares of LHC Group by 1.6% in the first quarter. Rhumbline Advisers now owns 85,486 shares of the health services provider’s stock valued at $9,477,000 after acquiring an additional 1,384 shares in the last quarter. Comerica Bank lifted its position in shares of LHC Group by 4.1% in the first quarter. Comerica Bank now owns 30,990 shares of the health services provider’s stock valued at $3,426,000 after acquiring an additional 1,231 shares in the last quarter. Finally, Mason Street Advisors LLC lifted its position in shares of LHC Group by 3.5% in the first quarter. Mason Street Advisors LLC now owns 9,380 shares of the health services provider’s stock valued at $1,040,000 after acquiring an additional 319 shares in the last quarter. Institutional investors and hedge funds own 90.15% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Featured Article: Marijuana Stocks

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.